Skip to main content

Table 5 Organomegaly, wasting and stunting in older Schistosoma mansoni-positive secondary school children at baseline and year five

From: Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya

 

Baseline

Year five

P-value

All 13–18 year old

n = 178 (%)

n = 37 (%)

 

Hepatomegaly alone

24 (13.5)

4 (10.8)

0.793

Hepatosplenomegaly

31 (17.4)

4 (10.8)

0.463

Splenomegaly alone

33 (18.5)

6 (16.2)

0.819

Normal

90 (50.6)

23 (62.2)

0.211

Stunting

8 (4.5)

2 (5.4)

0.683

Wasting

1 (0.6)

2 (5.4)

0.077

13–18 years old malaria positive

n = 58 (%)

n = 13 (%)

 

Hepatomegaly

6 (10.3)

2 (15.4)

0.633

Hepatosplenomegaly

15 (25.9)

2 (15.4)

0.720

Splenomegaly

18 (31.0)

1 (7.7)

0.162

Normal

19 (32.8)

8 (61.5)

0.065

Stunting

3 (5.2)

1 (7.7)

0.563

Wasting

0 (0.0)

0 (0.0)

0.999

13–18 years old malaria negative

n = 120 (%)

n = 24 (%)

 

Hepatomegaly

18 (15.0)

2 (8.33)

0.528

Hepatosplenomegaly

16 (13.3)

2 (8.3)

0.738

Splenomegaly

15 (12.5)

5 (20.8)

0.330

Normal

71 (59.2)

15 (62.5)

0.823

Stunting

5 (4.2)

1 (4.2)

0.999

Wasting

1 (0.8)

2 (8.3)

0.072

  1. Differences among the two study groups were evaluated using Fisher’s exact test